Program Overview

The KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in CKD in Adults states: "The finding of a TSAT less than 20% coupled with a ferritin level greater than 500 ng/mL poses a particularly difficult problem for clinicians."

Join Daniel Coyne, MD as he shares the results of an important new clinical trial, Dialysis Patients' Response to IV Iron With Elevated Ferritin (DRIVE), and examines the safety and efficacy of sodium ferric gluconate in managing the anemic hemodialysis patient who is receiving adequate epoetin treatment, with a serum ferritin level between 500 and 1200 ng/mL and TSAT ≤25%. You will find the results to be impressive.

Faculty Information
Daniel Coyne, MD
Professor of Medicine
Washington University School of Medicine
St. Louis, Missouri